EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Five-Year Clinical Performance and Patient-Reported Outcomes of Mentor MemoryGel and MemoryShape Breast Implants (GLOW Study)

Amy Alderman, David Caplin, Roger Wixtrom, Jay Turetzky iD, Natalie Tomaszewski, William J Kane

Aesthetic Surgery Journal · 06.11.2026

DOI: 10.1093/asj/sjag234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aesthetic Surgery Journal, online erschienen am 06.11.2026. Verfasst von Amy Alderman und 5 weiteren Autor:innen. Beteiligte Einrichtung: North Atlanta Plastic Surgery, Alpharetta, GA. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long-term clinical safety and patient-reported outcomes are critical for guiding breast implant selection. Current implant options include MemoryGel (round) and MemoryShape (anatomical) implants, which are designed to meet diverse anatomical and aesthetic needs.

Objectives

To measure interim 5-year safety and effectiveness outcomes of MemoryGel (including MemoryGel Xtra) and MemoryShape breast implants in the 10-year Mentor MemoryGel and MemoryShape Combined Cohort Clinical Study.

Methods

Participants received breast augmentation or reconstruction with MemoryGel round (referred to as “MemoryGel non-Xtra”), MemoryGel Xtra round, or MemoryShape implants in this prospective, multicenter clinical trial. To assess device safety, incidence of complications and reoperations was estimated using Kaplan-Meier analyses; effectiveness was evaluated using a validated patient-reported questionnaire (BREAST-Q).

Results

Overall, 2,043 patients received MemoryGel non-Xtra implants, 289 received MemoryGel Xtra, and 397 received MemoryShape in augmentation or reconstruction procedures. The study was not designed for direct comparisons between devices. For the primary augmentation cohort, estimated 5-year incidences of Baker grade III/IV capsular contracture were 1.42% (MemoryGel Xtra), 5.16% (MemoryGel non-Xtra), and 0.31% (MemoryShape); implant-related reoperation rates were 2.9%, 5.49%, and 3.37%; and explantation rates were 5.90%, 6.39%, and 4.01%, respectively. BREAST-Q satisfaction with breasts, psychosocial well-being, and sexual well-being improved significantly from baseline to Year 5 (p < 0.001) across all primary augmentation cohorts, and physical well-being returned to baseline levels.

Conclusions

These 5-year interim results support a finding of long-term safety, high patient satisfaction, and sustained quality-of-life benefits of MemoryGel and MemoryShape breast implants.

Autor:innen und Institutionen

  • North Atlanta Plastic Surgery, Alpharetta, GA.
  • Parkcrest Plastic Surgery, St. Louis, MO.
  • LSCI Global, St. Augustine, FL.
  • Mentor Worldwide LLC, Irvine, CA.
  • Senior biostatistician at Johnson and Johnson, New Brunswick, NJ.

ORCID-Profile: Jay Turetzky

Zitieren

APA

Alderman, A., Caplin, D., Wixtrom, R., Turetzky, J., Tomaszewski, N., & Kane, W. J. (2026). Five-Year Clinical Performance and Patient-Reported Outcomes of Mentor MemoryGel and MemoryShape Breast Implants (GLOW Study). Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjag234

Vancouver

Alderman A, Caplin D, Wixtrom R, Turetzky J, Tomaszewski N, Kane WJ. Five-Year Clinical Performance and Patient-Reported Outcomes of Mentor MemoryGel and MemoryShape Breast Implants (GLOW Study). Aesthetic Surgery Journal. 2026. doi:10.1093/asj/sjag234

BibTeX
@article{Alderman2026,
  author = {Alderman, Amy and Caplin, David and Wixtrom, Roger and Turetzky, Jay and Tomaszewski, Natalie and Kane, William J},
  title = {Five-Year Clinical Performance and Patient-Reported Outcomes of Mentor MemoryGel and MemoryShape Breast Implants (GLOW Study)},
  journal = {Aesthetic Surgery Journal},
  year = {2026},
  doi = {10.1093/asj/sjag234}
}
Kostenlos starten →